The reason they employed their own in house legal/engineer for patents is to avoid going to court.
The way to avoid going to court is monitor patents and if there is an issue provide submissions to the patent office concerning the offending application. This is what happened with Intel and the patent office declined their patent to the extent it infringed Brainchips patents.
Intel was then in the position where it either accepted the decision of the patent office or commenced an action against the patent office not Brainchip. It accepted the patent office's decision.
Prior to Brainchip employing their own in house legal/engineer for this purpose they relied upon Peter van der Made, interns who were brought in on a consistent rolling basis trawling the patent registers and external lawyers who in the words of Ken Scarince were very expensive.
So in answer to your question Brainchip are actually not increasing their spend and in doing so not facing the prospect of rushing off to court every five seconds.
As a company they have been very clever about how they are handling this issue of protecting their patents.
From a lawyers perspective if you do need to go to court and expert evidence is required a good lawyer will qualify the best expert in the field. An even better lawyer will qualify every expert in the field before they commence proceedings to ensure the other side cannot match the quality of the expert evidence. The unique nature of the AKIDA technology means that the ultimate expert in all the world is in fact Peter van der Made followed by those engineers who have worked with him at Brainchip and appear on the Brainchip patents. If there ever was litigation Brainchip is in the box seat to produce the best experts and win their case.
My opinion only DYOR
FF
AKIDA BALLISTA
- Forums
- ASX - By Stock
- BRN
- 2021 BRN Discussion
BRN
brainchip holdings ltd
Add to My Watchlist
8.97%
!
21.3¢

2021 BRN Discussion, page-18670
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
21.3¢ |
Change
0.018(8.97%) |
Mkt cap ! $425.3M |
Open | High | Low | Value | Volume |
19.5¢ | 21.8¢ | 19.5¢ | $2.073M | 9.928M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 411696 | 21.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 1222912 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 803290 | 0.210 |
26 | 1398886 | 0.205 |
33 | 1450131 | 0.200 |
27 | 1130633 | 0.195 |
68 | 2442151 | 0.190 |
Price($) | Vol. | No. |
---|---|---|
0.215 | 1206197 | 23 |
0.220 | 2561265 | 57 |
0.225 | 1890677 | 26 |
0.230 | 1340682 | 31 |
0.235 | 353848 | 14 |
Last trade - 13.22pm 01/07/2025 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online